| 000 | 01322 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515152724.0 | ||
| 264 | 0 | _c20090203 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2008.10.042 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDancey, J E | |
| 245 | 0 | 0 |
_aRecommendations for the assessment of progression in randomised cancer treatment trials. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cJan 2009 |
||
| 300 |
_a281-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBias |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aEndpoint Determination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aDodd, L E | |
| 700 | 1 | _aFord, R | |
| 700 | 1 | _aKaplan, R | |
| 700 | 1 | _aMooney, M | |
| 700 | 1 | _aRubinstein, L | |
| 700 | 1 | _aSchwartz, L H | |
| 700 | 1 | _aShankar, L | |
| 700 | 1 | _aTherasse, P | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 45 _gno. 2 _gp. 281-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2008.10.042 _zAvailable from publisher's website |
| 999 |
_c18548894 _d18548894 |
||